Table: begin end state 1 11 cytoplasmic 12 29 transmembrane 30 35 non-cytoplasmic 36 55 transmembrane 56 94 cytoplasmic 95 114 transmembrane 115 120 non-cytoplasmic 121 141 transmembrane 142 162 cytoplasmic 163 186 transmembrane 187 192 non-cytoplasmic 193 212 transmembrane 213 223 cytoplasmic 224 244 transmembrane 245 257 non-cytoplasmic 258 279 transmembrane 280 286 cytoplasmic 287 306 transmembrane 307 327 non-cytoplasmic 328 348 transmembrane 349 367 cytoplasmic 368 388 transmembrane 389 406 non-cytoplasmic 407 421 transmembrane 422 424 non-cytoplasmic 425 437 cytoplasmic 438 456 transmembrane 457 467 non-cytoplasmic 468 487 transmembrane 488 512 cytoplasmic 513 532 transmembrane 533 544 non-cytoplasmic 545 569 transmembrane 570 575 cytoplasmic 576 599 transmembrane 600 645 non-cytoplasmic 646 668 transmembrane 669 688 cytoplasmic
Input: >PfGW456L13_1444 MKNNNSPLRHLPWLVLAIVGACALGVVALRRGEAINALWIVVAAVAIYLVAYRYYSLFIA NNVMQLDARRATPAVLNNDGLDYVPTNKHILFGHHFAAIAGAGPLVGPVLAAQMGYLPGT LWLIAGVVLAGAVQDFMVLFMSTRRNGRSLGDMVREEMGRIPGTIALFGCFLIMIIILAV LALIVVKALAESPWGIFTVMATIPIAMFMGIYMRYIRPGRIGEISVIGVLLLLGSIWLGG QIAADPVWAKAFSFTGIQITWMLIGYGFVAAVLPVWLILAPRDYLSTFLKIGTIVALAIG ILVTMPELKMPALTQFVDGTGPVWKGGLFPFLFITIACGAVSGFHALISSGTTPKLLDNE TNARYIGYGGMLMESFVAIMAMVAASVIEPGVYFAMNSPAAVVGGDVVAVATAVSNWGFA ITPEALQAVAHDIGETTILARAGGAPTLAVGIAQILHSVLPGENTMAFWYHFAILFEALF ILTAVDAGTRAGRFMLQDLLGSFVPALKRTESWTANLIATAGCVAMWGWLLYQGVIDPLG GINTLWPLFGISNQMLAGIALMLGTVVLIKMKRQRYVWVTMLPAVWLLICTTTAGFIKLF DANPAIGFLSLAKKYSDALANGQILAPAKDITQMQHVIFNAYTNATLTALFLFVVFSILF YALKVGIAAWGKKERTDKESPFQALPDA
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server